Category: Pharma & Biotech NEWS | Series “Re…
Read more →
Category: Pharma & Biotech NEWS | Series “Re…
Read more →
Category: Pharma & Biotech NEWS | Series “Re…
Read more →
Category: Pharma & Biotech NEWS | Series “Re…
Read more →
This final part pulls together the structural dr…
Read more →
Beyond oncology and metabolic, partnering has ma…
Read more →
Obesity and type 2 diabetes are massive in clini…
Read more →
Oncology is the tip of the spear for China-origi…
Read more →
Introduction: Innovation Means Nothing Without A…
Read more →
Introduction: Novo’s Layoff as a Symbol of Indus…
Read more →
In recent years, “exit” has become one of the mo…
Read more →
Introduction As of August 2025, the obesity drug…
Read more →
In July 2025, the FDA began publishing past Comp…
Read more →
Fierce Biotech's "Layoff Tracker 2025" has captu…
Read more →
Introduction Over the past decade, major Japanes…
Read more →
Introduction Between 2015 and 2025, global pharm…
Read more →
Strategic Review: Investing in Marketed Products…
Read more →
Strategic Overview: Otsuka’s Global Expansion in…
Read more →
Strategic Review: Global Expansion through ADC-F…
Read more →
Strategic Review: Rare Disease, GI, Vaccines, an…
Read more →
Strategic Review: From Cystic Fibrosis to Gene E…
Read more →
Strategic Review: Antibody Innovation Meets Gene…
Read more →
Strategic Overview: Expanding from Diabetes to O…
Read more →
Strategic Review: Shifting from Antivirals to On…
Read more →